Evidence map›Paper›PMID 36305765›Full record

ArticleProtein science : a publication of the Protein Society2022

Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2.

Cyril Planchais, Alejandra Reyes-Ruiz, Robin Lacombe, Alessandra Zarantonello, Maxime Lecerf, Margot Revel, Lubka T Roumenina, Boris P Atanasov, Hugo Mouquet, Jordan D Dimitrov

Open access · hybridAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Evolution of a fuzzy ribonucleoprotein complex in viral assembly.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Cyril PlanchaisLaboratory of Humoral Immunology, Institut Pasteur, Université Paris Cité, INSERM U1222, Paris, France.
Alejandra Reyes-RuizCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Robin LacombeCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Alessandra ZarantonelloCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Maxime LecerfCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Margot RevelCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Lubka T RoumeninaCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.
Boris P AtanasovInstitute of Organic Chemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Hugo MouquetLaboratory of Humoral Immunology, Institut Pasteur, Université Paris Cité, INSERM U1222, Paris, France.
Jordan D DimitrovCentre de Recherche des Cordeliers, INSERM, CNRS, Sorbonne Université, Université de Paris, Paris, France.ORCID 0000-0001-8536-8995
Centre National de la Recherche Scientifique · FRInserm · FRBulgarian Academy of Sciences · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 infects cells by attachment to its receptor-the angiotensin converting enzyme 2 (ACE2). Regardless of the wealth of structural data, little is known about the physicochemical mechanism of interactions of the viral spike (S) protein with ACE2 and how this mechanism has evolved during the pandemic. Here, we applied experimental and computational approaches to characterize the molecular interaction of S proteins from SARS-CoV-2 variants of concern (VOC). Data on kinetics, activation-, and equilibrium thermodynamics of binding of the receptor binding domain (RBD) from VOC with ACE2 as well as data from computational protein electrostatics revealed a profound remodeling of the physicochemical characteristics of the interaction during the evolution. Thus, as compared to RBDs from Wuhan strain and other VOC, Omicron RBD presented as a unique protein in terms of conformational dynamics and types of non-covalent forces driving the complex formation with ACE2. Viral evolution resulted in a restriction of the RBD structural dynamics, and a shift to a major role of polar forces for ACE2 binding. Further, we investigated how the reshaping of the physicochemical characteristics of interaction affects the binding specificity of S proteins. Data from various binding assays revealed that SARS-CoV-2 Wuhan and Omicron RBDs manifest capacity for promiscuous recognition of unrelated human proteins, but they harbor distinct reactivity patterns. These findings might contribute for mechanistic understanding of the viral tropism and capacity to evade immune responses during evolution.

Indexed as

COVID-19SARS-CoV-2Angiotensin-Converting Enzyme 2HumansPeptidyl-Dipeptidase AProtein BindingSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase ASpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2binding promiscuityprotein electrostaticsprotein-protein interactionsSARS-CoV-2thermodynamicsvirus evolution

Identifiers

PMID36305765
PMCPMC9597384
OpenAlexW4307848517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.